{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T14:40:00Z","timestamp":1712587200138},"reference-count":29,"publisher":"Georg Thieme Verlag KG","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1055\/a-1937-8337","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T23:08:52Z","timestamp":1696460932000},"page":"1227-1235","source":"Crossref","is-referenced-by-count":1,"title":["Update: Diagnostik und Therapie der pulmonalen Tuberkulose"],"prefix":"10.1055","volume":"148","author":[{"given":"Inna","family":"Friesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunar","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kuhns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e830","DOI":"10.1093\/cid\/ciaa1402","article-title":"Subclinical Tuberculosis Disease-A Review and Analysis of Prevalence Surveys to Inform Definitions, Burden, Associations, and Screening Methodology","volume":"73","author":"B Frascella","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijid.2016.10.016","article-title":"Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade","volume":"56","author":"D Cazabon","year":"2017","journal-title":"Int J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e00421","DOI":"10.1128\/jcm.00421-22","article-title":"Accuracy of Tongue Swab Testing Using Xpert MTB-RIF Ultra for Tuberculosis Diagnosis","volume":"60","author":"A Andama","year":"2022","journal-title":"J Clin Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jinf.2022.05.010","article-title":"Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis","volume":"85","author":"A Dhana","year":"2022","journal-title":"J Infect"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1473-3099(21)00261-9","article-title":"The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-\u03b3 release assays: a systematic review and meta-analysis","volume":"22","author":"M Krutikov","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1055\/a-1934-8303","article-title":"Tuberkulose im Erwachsenenalter: Eine S2k-Leitlinie zur Diagnostik und Therapie, Chemopr\u00e4vention und Chemoprophylaxe der Tuberkulose im Erwachsenenalter des Deutschen Zentralkomitees zur Bek\u00e4mpfung der Tuberkulose e. V. (DZK) und der Deutschen Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin e. V. (DGP)","volume":"76","author":"T Schaberg","year":"2022","journal-title":"Pneumologie"},{"key":"ref9","volume-title":"MIQ 05: Tuberkulose Mykobakteriose: Qualit\u00e4tsstandards in der mikrobiologisch-infektiologischen Diagnostik. 2. Aufl","author":"E Richter","year":"2013"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1056\/NEJMoa1614915","article-title":"Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis","volume":"377","author":"YL Xie","year":"2017","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e02983","DOI":"10.1128\/JCM.02983-20","article-title":"Evaluation of the Roche cobas MTB and MTB-RIF\/INH Assays in Samples from Germany and Sierra Leone","volume":"59","author":"D Nadarajan","year":"2021","journal-title":"J Clin Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz065","article-title":"rpoB Mutations Causing Discordant Rifampicin Susceptibility in Mycobacterium tuberculosis: Retrospective Analysis of Prevalence, Phenotypic, Genotypic, and Treatment Outcomes","volume":"6","author":"NR Mvelase","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"The CRyPTIC Consortium and the 100,000 Genomes Project. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00116-1","article-title":"Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study","author":"I Finci","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2002338","DOI":"10.1183\/13993003.02338-2020","article-title":"Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs","volume":"57","author":"A Jouet","year":"2021","journal-title":"Eur Respir J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13073-020-00793-8","article-title":"MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era","volume":"12","author":"P Beckert","year":"2020","journal-title":"Genome Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"87s","DOI":"10.1183\/09031936.02.00309102","article-title":"Tuberculosis therapy: past, present and future","volume":"20","author":"MD Iseman","year":"2002","journal-title":"Eur Respir J"},{"key":"ref20","first-page":"S231","article-title":"Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946\u20131986, with relevant subsequent publications","volume":"3","author":"W Fox","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref21","first-page":"265","article-title":"Fluoroquinolones: a new treatment for tuberculosis?","volume":"2","author":"SH Gillespie","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","article-title":"Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis","volume":"371","author":"SH Gillespie","year":"2014","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","article-title":"A four-month gatifloxacin-containing regimen for treating tuberculosis","volume":"371","author":"CS Merle","year":"2014","journal-title":"The New England journal of medicine"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","article-title":"High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis","volume":"371","author":"A Jindani","year":"2014","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1164\/rccm.201407-1264OC","article-title":"A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis","volume":"191","author":"MJ Boeree","year":"2015","journal-title":"American journal of respiratory and critical care medicine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/AAC.00912-12","article-title":"Dose-ranging comparison of rifampin and rifapenine in two pathologically distinct murine models of tuberculosis","volume":"56","author":"IM Rosenthal","year":"2012","journal-title":"AntimicrobAgents Chemother"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","article-title":"Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis","volume":"384","author":"SE Dorman","year":"2021","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2200388","DOI":"10.1183\/13993003.00388-2022","article-title":"Rifapentine access in Europe: growing concerns over key tuberculosis treatment component","volume":"59","author":"L Guglielmetti","year":"2022","journal-title":"Eur Respir J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1056\/NEJMoa2212537","article-title":"Treatment Strategy for Rifampin-Susceptible Tuberculosis","volume":"388","author":"NI Paton","year":"2023","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e1003008","DOI":"10.1371\/journal.pmed.1003008","article-title":"Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data","volume":"17","author":"AS Dean","year":"2020","journal-title":"PLoS Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa2104535","article-title":"Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children","volume":"386","author":"A Turkova","year":"2022","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1159\/000512531","article-title":"Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge","volume":"100","author":"BW Allwood","year":"2021","journal-title":"Respiration"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"566608","DOI":"10.3389\/fimmu.2020.566608","article-title":"Perspective for Precision Medicine for Tuberculosis","volume":"11","author":"C Lange","year":"2020","journal-title":"Front Immunol"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1937-8337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T23:09:00Z","timestamp":1696460940000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1937-8337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":29,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,9,15]]},"published-print":{"date-parts":[[2023,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1937-8337","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}